Bartłomiej Kost

Dr. Bartłomiej Kost

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Open access
BKBartłomiej Kost
Bartłomiej Kost
MSMariia Svyntkivska
Mariia Svyntkivska
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
TMTomasz Makowski
Tomasz Makowski
EPEwa Piorkowska
Ewa Piorkowska
BTBiela Tadeusz
Biela Tadeusz
Microbial infections lead to elevated inflammatory responses, which usually result in prolonged and incomplete wound healing. Therefore, there is an increasing demand for biodegradable fibres that are effective against a different range of microorganisms, especially those with antibiotic resistance. Herein, quercetin-(Q)-loaded polylactide-based fibres were developed using the electrospinning technique. Since Q exhibits low chemical stability, we used star-shaped polylactides (PLAs) with a β-CD core to host Q by inclusion complexation. To enhance the stability of the fibres and additionally entrap the Q between polymeric chains, we adapted supramolecular cross-linking by the stereocomplexation of PLAs with opposite configurations. As a control, we prepared an additional formulation of star-shaped/commercial PLA/Q for the preparation of nonwovens in which the β-CD moiety was not present. All developed fibres were smooth and continuous, with an average diameter of 37 μm. Although nonwovens did not possess diffusible activity, good antibacterial effects against Staphylococcus aureus (S. aureus), Escherichia coli (E.coli) and Klebsiella pneumoniae (K. pneumoniae) were observed. All these features validate the proposed approach, in which different supramolecular interactions were used to modify the properties of PLA-based fibres and, most importantly, show their great potential usefulness against microbial infections.

28 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
BKBartłomiej Kost
Bartłomiej Kost
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
MSMarta Socka
Marta Socka
MBMałgorzata Baśko
Małgorzata Baśko
BTBiela Tadeusz
Biela Tadeusz
Cyclodextrins (CD) are a group of cyclic oligosaccharides with a cavity/specific structure that enables to form inclusion complexes (IC) with a variety of molecules through non-covalent host-guest interactions. By an elegant combination of CD with biocompatible, synthetic and natural polymers, different types of universal drug delivery systems with dynamic/reversible properties have been generated. This review presents the design of nano- and micro-carriers, hydrogels, and fibres based on the polymer/CD supramolecular systems highlighting their possible biomedical applications. Application of the most prominent hydrophobic aliphatic polyesters that exhibit biodegradability, represented by polylactide and polycaprolactone, is described first. Subsequently, particular attention is focused on materials obtained from hydrophilic polyethylene oxide. Moreover, examples are also presented for grafting of CD on polysaccharides. In summary, we show the application of host-guest interactions in multi-component functional biomaterials for controlled drug delivery.

1 May 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
MSMarta Socka
Marta Socka
TMTomasz Makowski
Tomasz Makowski
BKBartłomiej Kost
Bartłomiej Kost
MCMarcin Cieslak
Marcin Cieslak
KKKarolina Królewska-Golińska
Karolina Królewska-Golińska

7 December 2018 in Polymer International
Verified
Journal Article
Closed access
PDF file
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
MSMarta Socka
Marta Socka
BKBartłomiej Kost
Bartłomiej Kost

1 November 2019 in European Polymer Journal
Verified
Journal Article
Open access
BKBartłomiej Kost
Bartłomiej Kost
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
MCMarcin Cieślak
Marcin Cieślak
KKKarolina Królewska-Golińska
Karolina Królewska-Golińska
TMTomasz Makowski
Tomasz Makowski
TBTadeusz Biela
Tadeusz Biela

1 December 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Open access
Marek BrzezinskiMarek Brzezinski
Marek Brzezinski
BKBartłomiej Kost
Bartłomiej Kost
SWStefanie Wedepohl
Stefanie Wedepohl
MSMarta Socka
Marta Socka
TBTadeusz Biela
Tadeusz Biela
MCMarcelo Calderon
Marcelo Calderon
Lung cancer is the leading cause of cancer death because of smoking and air pollution. Therefore, new ideas should be provided for lung cancer treatment in which the delivery of anticancer drugs to the local tumor site can be achieved. For this purpose, we propose the use of stereocomplexed spherical microspheres with sizes between 0.5 and 10 μm loaded with doxorubicin (DOX) to be administered through the nasal route. In order to gain control over the microsphere morphology, size, and drug loading capacity, we systematically studied the influence of the solvent used for preparation and the functionalization of their building blocks, namely poly-l-lactide (PLLA) and poly-d-lactide (PDLA) with blocked or unblocked l-proline moieties. We could demonstrate that DOX release is generally determined by the size of the microspheres. The antiproliferative activity of DOX released from the different microspheres was shown in vitro using the A549 lung cancer cell line as a model. Moreover, when in direct contact to the cancer cells, smaller microspheres were uptaken and could serve as a reservoir for local drug release. Our findings not only provide a novel strategy to prepare PLA microspheres with controllable morphology and release of anti-cancer drugs but also offer additional possibilities for the application of stereocomplexed particles in anticancer therapy, with suitable sizes for nasal administration.